Atox1-cyclin D1 loop activity is critical for survival of tumor cells with inactivated TP53

Oleg A Kuchur1, Sofya S Pogodaeva1, Anna V Shcherbakova1

  • 1National Research University ITMO, 197101 St. Petersburg, Russia.

Bioscience Reports
|May 30, 2024
PubMed

Insights

The p53 protein influences cell division and chemoresistance. In p53-negative tumors, the copper transporter Atox1 and cyclin D1 form a feedback loop, enhancing proliferation and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The p53 protein is crucial for regulating apoptosis, DNA repair, and cell division, and its loss is common in tumors, leading to chemoresistance.
  • Tumor cell proliferation is linked to transition metal metabolism, with the copper transporter Atox1 activating cyclin D1 transcription.
  • p53 and Atox1 have opposing roles in regulating cyclin D1 and cell cycle progression, but their interaction's role in cell survival is unclear.

Purpose of the Study:

  • To investigate the interaction between Atox1, cyclin D1, and the p53 gene status in tumor cell proliferation.
  • To understand the contribution of the Atox1-cyclin D1 feedback loop to cell survival in the context of p53 functionality.

Main Methods:

  • Utilized A549 and HepG2 cell lines with varying TP53 gene status.
  • Analyzed gene expression levels of ATOX1 and CCND1.
  • Assessed the impact of gene suppression on apoptosis.

Main Results:

  • A positive feedback loop between Atox1 and cyclin D1 was identified, with its activity dependent on TP53 gene status.
  • TP53 inactivation in A549 and HepG2 cells led to enhanced expression of ATOX1 and CCND1.
  • Suppression of ATOX1 and CCND1 in p53-inactivated cells resulted in significant apoptosis.

Conclusions:

  • The interplay between Atox1, cyclin D1, and p53 status significantly impacts tumor cell proliferation and survival.
  • Targeting the Atox1-cyclin D1 feedback loop in p53-negative tumors presents a potential strategy for combined cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K